Walleye Capital’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Walleye Capital’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-33,101	Closed	-$1.59M	–	1166
2020 Q1	$1.59M	Sell	33,101 -45,236	-58%	-$2.1M	0.35%	74
2019 Q4	$3.68M	Buy	+78,337	New	+$3.46M	0.24%	82

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Walleye Capital's RARX Position: Q2 2020 in Review

Walleye Capital sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 33,101 shares — an estimated $1.59M sold.

Walleye Capital first reported a position in RARX in Q4 2019 and held it in 2 quarters. The position peaked at $3.68M in Q4 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Walleye Capital reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Walleye Capital sold 33,101 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $1.59M.
Walleye Capital first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
Walleye Capital's Ra Pharmaceuticals, Inc. Common Stock position peaked at $3.68M in Q4 2019.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Walleye Capital's 13F filing for Q2 2020, filed 14 Aug 2020.